Stockreport

Eli Lilly outlays $1.12bn for hearing loss gene therapy partnership [Yahoo! Finance]

MeiraGTx Holdings plc - Ordinary Shares  (MGTX) 
PDF The partnership will see the two companies develop and commercialise programmable recombinase-based treatments targeting hearing loss indications. In exchange for using [Read more]